Keep up to datewith all the industry news and break throughs, press releases and activities

Newsletter Sign-up

Selcia Newsletter delivered
direct to your Inbox

Please sign me up for occasional news updates from Selcia. Privacy Policy

Submit >

News > Selcia Radiolabelling News

February 10, 2010

Selcia has consolidated its position as provider of choice for 14C custom radiolabelling services by up-grading its Ongar laboartories, offering GMP-concepts radiolabelling and maintaining its independent posittion as a 14C synthesis specialist.

Over the last two years Selcia Radiolabelling has consolidated its leading position as the provider of choice for carbon-14 radiolabelling services. In response to its solid and ever growing client base Selcia has strengthened its radiochemistry work force to 23 highly qualified synthetic chemists. In parallel the modern, top-spec laboratory space at its Ongar, UK facility has been expanded to provide 29 radiochemical fume cupboards including four dedicated GMP-concepts work places.

Selcia’s independent position and good relationship with leading CROs gives the client freedom to choose the most appropriate laboratory for their study, at the same time ensuring seamless 3-way communication and efficient delivery of the labelled test substance.

Selcia Radiolabelling supports customers in the pharma and biotech industries with GMP-concepts synthesis of 14-C radiolabelled API to support clinical studies such as phase-I mass balance or microdosing. Flexibility, stringent documentation and carefully controlled work practices ensure the clients individual quality requirements are matched and the relevant national and international legislation is strictly followed.

Selcia’s accomplished analytical group, operating in a GLP certified analytical facility, ensures the highest standards of purity backed up by an industry leading data package.

Selcia Radiolabelling supports the regulatory requirements of clients in the agrochemical, biocide, nutritional, cosmetic and other chemical industries by reliably delivering high quality radiolabelled test substances. An extensive data package demonstrates the radiolabel is of sufficient quality for the study. Selcia as a specialist in radiosynthesis is focused on furnishing the radiolabelled substance and has the necessary expertise and experience to coordinate the work in conjunction with the client and the contract laboratory to guarantee a smooth process.



Upcoming Events

21 February 2012 - 22 February 2012

13th Annual Phase I & IIa Clinical Trials London

Selcia to attend Informa's 13th Annual Phase I & IIa Clinical Trials in London, 21-22 February 2012

01 March 2012

SCI Academic Drug Discovery London UK

Selcia will participate in the SCI symposium Academic Drug Discovery: Programmes and Collaborations, at SCI HQ in London UK

06 March 2012

One Nucleus Bench to Boardroom Newmarket Racecourse

Selcia to attend the One Nucleus Bench to Boardroom event at Newmarket Racecourse, UK, on 6 March 2012

13 March 2012 - 14 March 2012

Discovery Chemistry Congress Munich

Selcia to present at Discovery Chemistry Congress in Munich, 13-14 March 2012.

19 March 2012 - 21 March 2012

BIO-Europe Spring Amsterdam

Selcia is attending BIO-Europe Spring in Amsterdam, 19-21 March 2012

17 April 2012 - 19 April 2012

Drug Discovery Chemistry San Diego

Selcia to present at Drug Discovery Chemistry: Fragment Based Drug Development in San Diego USA, 17-19 April 2012.